Format

Send to:

Choose Destination
See comment in PubMed Commons below
Br J Cancer. 2005 Sep 19;93(6):620-1.

High-dose chemotherapy and peripheral blood stem cell support in refractory gestational trophoblastic neoplasia.

Author information

  • 1YCR Academic Unit of Clinical Oncology, Weston Park Hospital, Whitham road, Sheffield S10 2SJ, UK.

Abstract

We present retrospectively our experience in the use of high-dose chemotherapy and haematopoietic stem cell support (HSCS) for refractory gestational trophoblastic neoplasia (GTN) in the largest series so far reported. In all, 11 patients have been treated at three Trophoblast Centres between 1993 and 2004. The conditioning regimens comprised either Carbop-EC-T (carboplatin, etoposide, cyclophosphamide, paclitaxel and prednisolone) or CEM (carboplatin, etoposide and melphalan) or ICE (ifosfamide, carboplatin, etoposide). Two patients had complete human chorionic gonadotrophin responses, one for 4 and the other for 12 months. Three patients had partial tumour marker responses for 1-2 months. High-dose chemotherapy and HSCS for GTN is still unproven. Further studies are needed, perhaps in high-risk patients who fail their first salvage treatment.

PMID:
16222307
[PubMed - indexed for MEDLINE]
PMCID:
PMC2361618
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Nature Publishing Group Icon for PubMed Central
    Loading ...
    Write to the Help Desk